Progreso hacia la eliminación de la hepatitis B y la hepatitis C mediante un modelo de financiación catalítica - Tashkent, Uzbekistán, 6 de diciembre de 2019 a 15 de marzo de 2020
Summary In 2016, the World Health Organization (WHO) set hepatitis elimination targets of 90% reduction in incidence and 65% reduction in mortality worldwide by 2030 (1). Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection prevalences are high in Uzbekistan, which lacks funding for meeting WHO’s targets. In the absence of large financial donor […]